Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00043641
What this trial is testing

HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 73
Not applicableStudy completedNCT02614950
What this trial is testing

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection

Who this might be right for
Acute HIV InfectionAntiretroviral Treatment Interruption
SEARCH Research Foundation 8
Testing effectiveness (Phase 2)Study completedNCT00000891
What this trial is testing

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 34
Early research (Phase 1)Study completedNCT00545558
What this trial is testing

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Who this might be right for
Hepatitis CHIV Infections
University of Cincinnati 18
Testing effectiveness (Phase 2)Study completedNCT00056797
What this trial is testing

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableUnknownNCT05996094
What this trial is testing

Antiretroviral Adherence and Drug-level Monitoring

Who this might be right for
HIV InfectionsAIDSAntiretroviral Therapy, Highly Active+2 more
Zamrotul Izzah 100
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Early research (Phase 1)Study completedNCT01546818
What this trial is testing

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Who this might be right for
HIV Infections
Sumagen 33
Testing effectiveness (Phase 2)Study completedNCT00987948
What this trial is testing

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

Who this might be right for
HIV Infections
University of Hawaii 15
Not applicableStudy completedNCT00013871
What this trial is testing

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Who this might be right for
HIV InfectionsHepatitis BMeasles+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT00432003
What this trial is testing

Effects of Anti-HIV Therapy on Nervous System Function

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 297
Early research (Phase 1)Study completedNCT00056758
What this trial is testing

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Post-approval studies (Phase 4)Looking for participantsNCT07476339
What this trial is testing

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

Who this might be right for
HIV -1 InfectionHIV (Human Immunodeficiency Virus)HIV+1 more
CAN Community Health 200
Post-approval studies (Phase 4)Study completedNCT00531557
What this trial is testing

Double Protease Inhibitor to Darunavir Switch Study

Who this might be right for
HIV Infections
St Stephens Aids Trust 12
Not applicableStudy completedNCT01625169
What this trial is testing

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

Who this might be right for
HIV
University of Southern California 9
Post-approval studies (Phase 4)Study completedNCT00487188
What this trial is testing

Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Who this might be right for
HIV Infections
Hoffmann-La Roche 47
Not applicableStudy completedNCT02012972
What this trial is testing

Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population

Who this might be right for
Antiretroviral Therapy, Highly ActiveDiabetes Mellitus, Type 2Cardiovascular Diseases
Boston University 354
Post-approval studies (Phase 4)Study completedNCT00960622
What this trial is testing

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Who this might be right for
HIV
St. Luke's-Roosevelt Hospital Center 17
Not applicableStudy completedNCT01225406
What this trial is testing

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Who this might be right for
This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy
The HIV Netherlands Australia Thailand Research Collaboration 56
Next Page